Thomas McConnon - 27 Feb 2023 Form 4/A - Amendment Insider Report for Goosehead Insurance, Inc. (GSHD)

Role
Director
Signature
/s/ P. Ryan Langston as Attorney-in-Fact for Thomas McConnon
Issuer symbol
GSHD
Transactions as of
27 Feb 2023
Transactions value $
$6,950,305
Form type
4/A - Amendment
Filing time
02 Mar 2023, 20:05:30 UTC
Date Of Original Report
01 Mar 2023
Previous filing
17 May 2022
Next filing
02 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GSHD Class A Common Stock Purchase $3.6M +80.3K +22.51% $44.84 437K 27 Feb 2023 By Wildcat Public Equity Partners, LLC F1, F2
transaction GSHD Class A Common Stock Purchase $188K +4.11K +0.94% $45.84 441K 27 Feb 2023 By Wildcat Public Equity Partners, LLC F2, F3
transaction GSHD Class A Common Stock Purchase $537K +12.1K +2.74% $44.37 453K 28 Feb 2023 By Wildcat Public Equity Partners, LLC F2, F4
transaction GSHD Class A Common Stock Purchase $921K +20.2K +4.46% $45.60 473K 28 Feb 2023 By Wildcat Public Equity Partners, LLC F2, F5
transaction GSHD Class A Common Stock Purchase $1.7M +36.8K +7.78% $46.25 510K 28 Feb 2023 By Wildcat Public Equity Partners, LLC F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price as these shares were purchased in multiple transactions at prices ranging from $44.58 to $45.57, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
F2 Shares are held by Wildcat Public Equity Partners, LLC. Mr. McConnon disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares.
F3 The price reported in Column 4 is a weighted average price as these shares were purchased in multiple transactions at prices ranging from $45.58 to $45.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
F4 The price reported in Column 4 is a weighted average price as these shares were purchased in multiple transactions at prices ranging from $44.01 to $44.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
F5 The price reported in Column 4 is a weighted average price as these shares were purchased in multiple transactions at prices ranging from $45.02 to $46.01, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
F6 The price reported in Column 4 is a weighted average price as these shares were purchased in multiple transactions at prices ranging from $46.02 to $46.38, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

Remarks:

Amended to reflect transactions within a one dollar price range and to update FN 1, the footnote to the Price in Column 4, to clarify that the shares were purchased and not sold.